Medops Technology Private Limited - MEDFIN

Recommendation: Upheld | Medium: Suo Motu - NAMS (TAMS)

In the absence of a written response along with documents for substantiation on or before the prescribed due date, the ASCI Secretariat considered this complaint exparte. The advertiser did not provide the details of the treatment procedure used for treating Varicose Veins, details regarding the medicines used and their approval status by the regulatory authorities. Claim, "Minimally invasive cure" was not substantiated with robust clinical evidence of patients who were treated and cured from varicose veins. The claim is misleading by exaggeration and is likely to lead to widespread disappointment in the minds of consumers. This advertisement is in contravention of Chapter I, 1.1, 1.4 and 1.5 of the ASCI Code. This complaint was UPHELD by Secretariat